VentriPoint Diagnostics Ltd.
OTC: VPTDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Hugh MacNaught
- Headquarters
- Toronto, Canada
- IPO year
- 2010
- Market cap
- $14.6M
- Website
- https://www.ventripoint.com
Loading VPTDF…
Loading profile data…Frequently asked questions about VPTDF
What does VentriPoint Diagnostics Ltd. (VPTDF) do?
VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform. This system, utilizing its VMS+ software, c...
Where does VPTDF trade?
VentriPoint Diagnostics Ltd. (VPTDF) trades on the Other OTC.
What sector is VPTDF in?
VentriPoint Diagnostics Ltd. (VPTDF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of VentriPoint Diagnostics Ltd.?
Hugh MacNaught is the chief executive officer of VentriPoint Diagnostics Ltd. (VPTDF).
Where is VentriPoint Diagnostics Ltd. headquartered?
VentriPoint Diagnostics Ltd. is headquartered in Canada.
Does VPTDF pay a dividend?
VentriPoint Diagnostics Ltd. (VPTDF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VPTDF go public?
VentriPoint Diagnostics Ltd. (VPTDF) completed its initial public offering in 2010.